March 25, 2022 01:42 PM EDT
Pharma
FDA+

EMA OKs two new drugs — J&J's BC­MA CAR-T for mul­ti­ple myelo­ma, As­traZeneca's Evusheld — plus 5 la­bel ex­pan­sions

Zachary Brennan

Senior Editor

The Eu­ro­pean Med­i­cines Agency’s CHMP on Fri­day rec­om­mend­ed two new drugs for ap­proval, As­traZeneca’s Evusheld to help pre­vent Covid-19, and John­son …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ca­griSe­ma’s weight loss da­ta dis­ap­point­ed. What does No­vo do next?

Deer­field wins fight to ac­quire Sin­gu­lar Ge­nomics, beat­ing out Tang Cap­i­tal’s Con­cen­tra

Ver­tex gets 'van­za triple' ap­proval and Trikaf­ta ex­pan­sion — with boxed warn­ings

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

CMS ex­plains what went in­to its first round of drug price ne­go­ti­a­tions

Three drug­mak­ers sue US over 340B dis­counts to STD clin­ics they al­lege don’t qual­i­fy

A service from the Financial Times